Skip to main content
Normal
Press Release RSS Feed (opens in new window)
Press Releases
Press release year list
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
February 26, 2026
SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously Treated Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer
February 23, 2026
Bristol Myers Squibb to Participate in the TD Cowen 46th Annual Health Care Conference
February 23, 2026
Bristol Myers Squibb Announces Positive Top-Line Results from Registrational Phase 2 Study of Luspatercept in Adults with Alpha (α)-Thalassemia
February 17, 2026
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Iberdomide in Patients with Relapsed or Refractory Multiple Myeloma
February 5, 2026
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025
February 4, 2026
Bristol Myers Squibb Teams Up with Kasey Keller to Share His Lymphoma Journey with Breyanzi
February 3, 2026
Bristol Myers Squibb Introduces "Change the Target. Change What’s Possible.” to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care
January 20, 2026
Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer
January 12, 2026
Bristol Myers Squibb Announces Positive Topline Results from Phase 3 SCOUT-HCM Trial Evaluating Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
January 2, 2026
Bristol Myers Squibb to Present at J.P. Morgan’s 44th Annual Healthcare Conference